In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 pill to identify safe dosing regimen. More participants is going to be enrolled within the identified monotherapy dosign routine. In Section B, members will acquire oral ruxolitinib and ABBV-744 might be given as "include-on" therapy. In Section https://abbv-744-in-the-treatment46801.blogsumer.com/31323293/the-best-side-of-abbv-744-clinical-trial-phase-1-results